Reuters logo
BRIEF-Biotron updates on Bit225 Phase 2 HIV-1 clinical trial
June 15, 2017 / 1:20 AM / 6 months ago

BRIEF-Biotron updates on Bit225 Phase 2 HIV-1 clinical trial

June 15 (Reuters) - Biotron Ltd

* Asx alert-bit225 phase 2 hiv-1 clinical trial update-bit.ax

* Trial headline results anticipated Q3 this year

* Independent data and safety monitoring committee unanimously voted to proceed with second, and larger, cohort at a higher dose Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below